Trial Profile

A Phase 0 Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Volunteers

Status: Completed

Phase of Trial: Phase 0

Latest Information Update: 04 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs GSK 137173A (Primary) ; Modified vaccinia Ankara (Primary) ; Candida antigen; Endotoxin
Indications Herpes zoster; Hypersensitivity; Monkeypox; Smallpox; Warts
Focus Pharmacodynamics
Sponsors Janssen Research & Development

Most Recent Events

27 Jan 2020 Status changed from recruiting to completed.
08 Nov 2019 Planned number of patients changed from 40 to 50.
08 Nov 2019 Planned End Date changed from 31 Jan 2020 to 26 Dec 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com